Thyrotoxicosis treatment with lithium corbanate. Cases reported

I. A. Matsueva, A. Dalmatova, T. V. Andreychenko, E. Grineva
{"title":"Thyrotoxicosis treatment with lithium corbanate. Cases reported","authors":"I. A. Matsueva, A. Dalmatova, T. V. Andreychenko, E. Grineva","doi":"10.14341/ket12709","DOIUrl":null,"url":null,"abstract":"Treatment of thyrotoxicosis caused by Graves’ disease or multinodular toxic goiter, is not difficult, in most cases, since the prescription of thionamides allows to normalize the level of thyroid hormones quickly and safety. But in a number of cases this therapy might be associated with serious side effects (agranulocytosis, toxic hepatitis, cholestasis), severe allergic reactions and also individual intolerance on thionamides. In such cases lithium carbonate is used, especially in severe thyrotoxic syndrome. It is known, that lithium can accumulate in the thyroid gland at a concentration 3–4 times higher than in the plasma. Perhaps, lithium uses Na+/I- ions. It can inhibit the synthesis and secretion thyroid hormones of thyroid gland. The article presents the cases reported the use of lithium carbonate in thyrotoxicosis treatment before thyroidectomy. Administering low doses of carbonate lithium (900 mg/ per day) renders significant decrease or normalization of thyroid hormones concentration within 7–14 days, thus it let perform thyroidectomy on the patients. No side effects have been identified with such a short course of lithium carbonate treatment.","PeriodicalId":10284,"journal":{"name":"Clinical and experimental thyroidology","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental thyroidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/ket12709","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Treatment of thyrotoxicosis caused by Graves’ disease or multinodular toxic goiter, is not difficult, in most cases, since the prescription of thionamides allows to normalize the level of thyroid hormones quickly and safety. But in a number of cases this therapy might be associated with serious side effects (agranulocytosis, toxic hepatitis, cholestasis), severe allergic reactions and also individual intolerance on thionamides. In such cases lithium carbonate is used, especially in severe thyrotoxic syndrome. It is known, that lithium can accumulate in the thyroid gland at a concentration 3–4 times higher than in the plasma. Perhaps, lithium uses Na+/I- ions. It can inhibit the synthesis and secretion thyroid hormones of thyroid gland. The article presents the cases reported the use of lithium carbonate in thyrotoxicosis treatment before thyroidectomy. Administering low doses of carbonate lithium (900 mg/ per day) renders significant decrease or normalization of thyroid hormones concentration within 7–14 days, thus it let perform thyroidectomy on the patients. No side effects have been identified with such a short course of lithium carbonate treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
公司酸锂治疗甲状腺毒症。病例报道
在大多数情况下,治疗由格雷夫斯病或多结节性中毒性甲状腺肿引起的甲状腺毒症并不困难,因为硫胺的处方可以快速安全地使甲状腺激素水平正常化。但在一些情况下,这种疗法可能与严重的副作用(粒细胞缺乏症、中毒性肝炎、胆汁淤积)、严重的过敏反应以及个体对硫胺的不耐受有关。在这种情况下使用碳酸锂,特别是在严重的甲状腺毒性综合征。众所周知,锂在甲状腺中的蓄积浓度比在血浆中的蓄积浓度高3-4倍。也许,锂使用Na+/I-离子。能抑制甲状腺甲状腺激素的合成和分泌。本文报道了在甲状腺切除术前应用碳酸锂治疗甲状腺毒症的病例。低剂量碳酸锂(900 mg/ d)治疗后7 ~ 14天甲状腺激素浓度明显下降或恢复正常,可行甲状腺切除术。如此短疗程的碳酸锂治疗没有发现任何副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Associations of thyroid status and thyroperoxidase antibodies with serum trace elements Features of achieving compensation of hypothyroisis in pregnant women Structural and morphologic characteristics of nodular goiter in chronic iodine deficiency status Investigation of neural network models application in EU-TIRADS thyroid nodules classification for personalization of thyroid gland ultrasound diagnostic Press release from the Endocrine Society ENDO 2022 Annual Conference
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1